Efficacy of Diclofenac Sodium Shock Wave Phonophoresis on Patients With Subacromial Impingement Syndrome

June 14, 2026 updated by: Radwa Fayek Hammam, MTI University

Efficacy of Diclofenac Sodium Shock Wave Phonophoresis on Patients With Subacromial Impingement Syndrome: A Randomized Controlled Trial

The goal of the study is to determine the effect of radial shock wave Phonophoresis on patients with impingement syndromes. to answer the following questions:

does shock wave Phonophoresis have and effect on pain? does shock wave Phonophoresis have and effect on shoulder function? does shock wave Phonophoresis have and effect on subacromial space? patients will be randomized to two groups: Group (A): patients will receive shock wave Phonophoresis plus conventional physical therapy.

Group (B): Patients will receive shock wave plus conventional Physical therapy.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Cairo, Egypt
        • Modern University for Technology and Information, Cairo, , Egypt
        • Contact:
          • Modern University for Technology and Information
          • Phone Number: 19041
          • Email: info@mti.edu.eg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients age range between 25-40 years ago.
  • Shoulder pain between 60- 120° with shoulder elevation (positive painful arch test).
  • Grade 2 impingement syndrome according to neer classification.

Exclusion Criteria:

  • Shoulder affected bilaterally
  • Receiving anesthetic or corticosteroid injections within 4 weeks of study enrollment
  • Surgery or previous fractures of the ipsilateral humeral head of the affected shoulder
  • Osteoarthritis in the acromioclavicular or glenohumeral joints

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: sodium diclofenac radial shock wave Phonophoresis plus conventional physical therapy
sodium diclofenac radial shock wave Phonophoresis plus conventional physical therapyc
Device: sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy
patients will receive radial shock wave Phonophoresis by ibuprofen in the form of 2000 shocks, 2.4 bars, 10 MHz frequency plus (strengthening and stretching exercises for subraspinatus muscle).
Active Comparator: radial shock wave plus conventional physical therapy
Device: radial shock wave therapy plus conventional physical therapy
patients will receive radial shock wave therapy ( 2000 shocks, 2.4 bars, 10 MHz), plus conventional physical therapy (strengthening and stretching exercises for subraspinatus muscle).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
shoulder pain
Time Frame: before the first session and after the last session ( four weeks)
shoulder pain will be measured by numerical pain scale
before the first session and after the last session ( four weeks)
subacromial space
Time Frame: before the first session and after the last session ( four weeks)
before the first session and after the last session ( four weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
shoulder function
Time Frame: Time Frame: before the first session and after the last session ( four weeks)
function will be measured by shoulder pain and disability index
Time Frame: before the first session and after the last session ( four weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

MTI University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 30, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

June 14, 2026

First Submitted That Met QC Criteria

June 14, 2026

First Posted (Actual)

June 18, 2026

Study Record Updates

Last Update Posted (Actual)

June 18, 2026

Last Update Submitted That Met QC Criteria

June 14, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pending (Other Grant/Funding Number: National Institutes of Allery and Infectious Diseases)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe